Personalized Protocol Cuts Opioid Prescribing After C-Section

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 2, 2024 -- A personalized protocol for opioid prescriptions after cesarean delivery reduces the median morphine milligram equivalents prescribed at discharge, according to a study recently published in the American Journal of Obstetrics & Gynecology.

Chinonye S. Imo, M.D., from Parkland Health in Dallas, and colleagues examined whether a transition from universal opioid prescribing to a personalized, patient-specific protocol decreases morphine milligram equivalents prescribed at discharge after cesarean delivery. Each patient was prescribed scheduled ibuprofen and acetaminophen, with a prescription for oxycodone tablets equal to five times the morphine milligram equivalents used in the 24 hours before discharge in the personalized prescribing group; previous traditional cohorts were routinely prescribed acetaminophen-codeine 300/30 mg (30 tablets). A total of 412 patients underwent cesarean delivery in the six weeks after initiation of the personalized prescribing protocol and were compared to 367 patients from before the initiation.

The researchers found that the median morphine milligram equivalents prescribed at discharge were lower with personalized prescribing (37.5 versus 135). In addition, 43 percent of patients were not prescribed opioids at discharge, while opioids at discharge were received by all patients in the traditional cohort. Nine phone calls were received to a hotline to address pain control issues after discharge; 11 patients (2.7 percent) presented to the emergency department for pain evaluation, none of whom required readmission or outpatient opioid prescription.

"Decreasing the flow of opioids into our community is imperative, both to prevent new opioid dependence in women undergoing cesarean delivery as well as ensuring pills are not diverted to others," lead author Elaine Duryea, M.D., from the University of Texas Southwestern Medical Center in Dallas, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords